IRM vs PPCB · P/E 136, rev $6.15B vs P/E 0.0, $3.9M cap
Iron Mountain Incorporated (IRM) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
PPCB does not have a complete income-statement cache yet.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the IRM and PPCB stock pages for the full models.
Not investment advice.